TIGD1 and colon adenocarcinoma: Prognosis analyses identified a correlation between elevated TIGD1 expression and shorter survival in liver hepatocellular carcinoma, colon adenocarcinoma, and the colorectal cancer cohort, reinforcing its pro-tumorigenic role in gastrointestinal cancers.